← Back to catalogue

INFINITI® Warfarin Amplification Mix

FDA UDI

Class II (US FDA UDI)

by Autogenomics, Inc

Identity

Trade Name
INFINITI® Warfarin Amplification Mix FDA UDI
Generic Name
Anticoagulant-resistance multiple genetic risk factor IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
CYP450 2C9 drug metabolizing enzyme and VKORC1 genotyping system FDA UDI
Model / Reference
03-3140-01 FDA UDI
Description
CYP450 2C9 drug metabolizing enzyme and VKORC1 genotyping system FDA UDI

Identifiers

Catalog Number
03-3140-01 FDA UDI
Primary DI / UDI-DI
00850009370181 FDA UDI
FDA Product Code
ODV FDA UDI
ODW FDA UDI
GMDN Term
Anticoagulant-resistance multiple genetic risk factor IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7750 FDA UDI
862.3360 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

INFINITI® Warfarin Amplification Mix by Autogenomics, Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Autogenomics, Inc

Sources (1)

  • FDA UDI b0ba6f17-9227-4205-a998-f20674710a89 37 fields · synced May 30, 2026